Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate.
暂无分享,去创建一个
G. Blake | I. Fogelman | S. Park-Holohan | G M Blake | I Fogelman | S J Park-Holohan | G J Cook | G. Cook
[1] W. Neuman,et al. THE CHEMICAL DYNAMICS OF BONE MINERAL , 1959 .
[2] R. Wootton. The single-passage extraction of 18F in rabbit bone. , 1986, Clinical science and molecular medicine.
[3] J. Barrio,et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] P. Valk,et al. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] T. Budinger,et al. PET instrumentation: what are the limits? , 1998, Seminars in nuclear medicine.
[6] J. Fleming,et al. Measurement of glomerular filtration rate with technetium-99m DTPA: comparison of plasma clearance techniques. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] J. Ekstrand,et al. Fluoride pharmacokinetics: Its implications in the fluoride treatment of osteoporosis , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] J. Siegel,et al. An analytical solution set for a four-compartment mixed mammillary/catenary model. , 1999, Nuclear medicine communications.
[9] P. Delmas,et al. Treatment of postmenopausal osteoporosis , 2002, The Lancet.
[10] I. Mccarthy,et al. Multiple tracer studies of bone uptake of 99mTc-MDP and 85Sr. , 1989, The American journal of physiology.
[11] P. Mcnair,et al. Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism. , 1984, Scandinavian journal of clinical and laboratory investigation.
[12] P. Marsden,et al. Differences in Skeletal Kinetics Between Vertebral and Humeral Bone Measured by 18F‐Fluoride Positron Emission Tomography in Postmenopausal Women , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[13] O. Israel,et al. Bone turnover in cortical and trabecular bone in normal women and in women with osteoporosis. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] F D Thomas,et al. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] P. Delmas,et al. Biochemical markers of bone turnover , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[17] M. Blau,et al. 18 F-fluoride for bone imaging. , 1972, Seminars in nuclear medicine.
[18] I. Fogelman,et al. Skeletal Nuclear Medicine , 1996 .
[19] J. Henriksen,et al. Arterio-venous concentration difference of [51Cr]EDTA after a single injection in man. Significance of renal function and local blood flow. , 1989, Clinical physiology.
[20] R. Recker,et al. Bone biopsy and histomorphometry in clinical practice. , 1994, Rheumatic diseases clinics of North America.
[21] John P. Bilezikian,et al. Principles of Bone Biology , 1996 .
[22] C. Weaver. Use of calcium tracers and biomarkers to determine calcium kinetics and bone turnover. , 1998, Bone.
[23] Harry K. Genant,et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.
[24] M. Rogers,et al. Bisphosphonates: from the laboratory to the clinic and back again. , 1999, Bone.
[25] D. Hamilton,et al. Body surface area correction in single-sample methods of glomerular filtration rate estimation. , 1999, Nuclear medicine communications.
[26] S. Papapoulos,et al. The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonates. , 2001, Seminars in nuclear medicine.
[27] E. M. Renkin. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. , 1959, The American journal of physiology.
[28] G. Whitford. Intake and Metabolism of Fluoride , 1994, Advances in dental research.
[29] J. Fleming,et al. Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysis. , 1987, The British journal of radiology.
[30] J. Loutit. Alkaline earth metabolism in adult man , 1973 .
[31] M. King,et al. Bone SPECT of the spine: a comparison of attenuation correction techniques. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] J. Digennaro,et al. Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. , 1998, The Journal of clinical endocrinology and metabolism.
[33] G. Blake,et al. Interpretation of bone densitometry studies. , 1997, Seminars in nuclear medicine.
[34] I. Fogelman,et al. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] M. D. Francis,et al. Bone scanning: radionuclidic reaction mechanisms. , 1976, Seminars in nuclear medicine.
[36] Charkes Nd,et al. Studies of Skeletal Tracer Kinetics. III. Tc-99m(Sn)methylenediphosphonate Uptake in the Canine Tibia as a Function of Blood Flow , 1979 .
[37] M. Feinsod,et al. Quantitative bone scintigraphy using SPECT. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] E. Siris. Paget's Disease of Bone , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] M. Phelps,et al. Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. , 1993, The Journal of clinical endocrinology and metabolism.
[40] M. Maisey,et al. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function. , 1984, The British journal of radiology.
[41] N. D. Charkes,et al. Studies of skeletal tracer kinetics: II. evaluation of a five-compartment model of [18F]fluoride kinetics in rats. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] O. Israel,et al. In vivo SPECT quantitation of bone metabolism in hyperparathyroidism and thyrotoxicosis. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] F. A. Smith,et al. Renal Clearance of Fluoride.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[44] G. Hodgson,et al. The relation of radionuclide uptake by bone to the rate of calcium mineralization. I: Experimental studies using 45Ca, 32P and 99Tcm-MDP. , 1989, The British journal of radiology.
[45] J. Staffurth,et al. The measurement of the extracellular fluid volume with radioactive bromine. , 1960, Clinical science.
[46] P. Tothill,et al. Invalidity of single‐passage measurements of the extraction of bone‐seeking tracers in rats and rabbits , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[47] R. Jain,et al. Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man. , 1978, The American journal of physiology.
[48] Makler Pt,et al. Studies of skeletal tracer kinetics. IV. Optimum time delay for Tc-99m(Sn) methylene disphosphonate bone imaging. , 1980 .
[49] R. Wootton,et al. Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: a relationship between blood flow and corrected apposition rate. , 1988, The Journal of clinical endocrinology and metabolism.
[50] H. Fleisch,et al. Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in vitro and Pathological Calcification in vivo , 1969, Science.
[51] P. Bartholdi,et al. Critical analysis of methods for analysing human calcium kinetics. , 1978, Journal of theoretical biology.
[52] W. Greig,et al. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[53] C. Philips,et al. Studies of skeletal tracer kinetics. I. Digital-computer solution of a five-compartment model of [18F] fluoride kinetics in humans. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[54] J. P. Lavender,et al. Blood flow and tracer uptake in normal and abnormal canine bone: comparisons with Sr-85 microspheres, Kr-81m, and Tc-99m MDP. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[55] A. Jones,et al. Comparison of 99mTc-labeled phosphate and phosphonate agents for skeletal imaging. , 1976, Seminars in nuclear medicine.
[56] F. Jamar,et al. The importance of endothelium and interstitial fluid in nuclear medicine , 1998, European Journal of Nuclear Medicine.
[57] J. Ekstrand,et al. Renal clearance of fluoride in a steady state condition in man: influence of urinary flow and pH changes by diet. , 2009, Acta pharmacologica et toxicologica.
[58] C. Slemenda,et al. Rates of Growth and Loss of Bone Mineral in the Spine and Femoral Neck in White Females , 1999, Osteoporosis International.
[59] A. Schoutens,et al. Bone Circulation and Vascularization in Normal and Pathological Conditions , 1993, NATO ASI Series.
[60] D. Hosking,et al. Studies in man with 18F. , 1972 .
[61] G Pearce,et al. The differing tempo of growth in bone size, mass, and density in girls is region-specific. , 1999, The Journal of clinical investigation.
[62] G. Blake,et al. Technical principles of dual energy x-ray absorptiometry. , 1997, Seminars in nuclear medicine.
[63] I. Fogelman,et al. Bone Scanning in Clinical Practice , 2012, Springer London.
[64] Montgomery Rd. Letter: Serum-albumin in Kwashiorkor. , 1975 .
[65] A. le Pape,et al. Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] T. Martin,et al. The hypercalcemia of malignancy: pathogenesis and management. , 1982, Metabolism: clinical and experimental.
[67] S. Pors Nielsen,et al. A single measurement of biochemical markers of bone turnover has limited utility in the individual person. , 1997, Scandinavian journal of clinical and laboratory investigation.
[68] A. Perkins,et al. Bisphosphonate Space Measurement in Paget's Disease of Bone Treated with APD , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[69] M. Grynpas,et al. Fluoride effects on bone crystals , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[70] W. Enneking,et al. 99m Tc-polyphosphate: histological localization in human femurs by autoradiography. , 1973, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[71] J. Lin,et al. Bisphosphonates: a review of their pharmacokinetic properties. , 1996, Bone.
[72] I. Edelman,et al. Anatomy of body water and electrolytes. , 1959, The American journal of medicine.
[73] S. Ben-Haim,et al. A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose. , 1989, Seminars in nuclear medicine.
[74] S. Bang,et al. Topographical distribution of fluoride in iliac bone of a fluoride‐treated osteoporotic patient , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[75] M. Francis,et al. Optimization of the ratio of stannous tin: ethane-1-hydroxy-1, 1-diphosphonate for bone scanning with 99mTc-pertechnetate. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[76] R. Wootton,et al. The single-passage extraction of 18F in rabbit bone. , 1974, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.
[77] D. Tosteson. Halide Transport in Red Blood Cells. , 1959 .
[78] I. Fogelman,et al. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[79] L. Mosekilde,et al. Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders , 1987, European journal of clinical investigation.
[80] W. Brenner,et al. Quantification of diphosphonate uptake based on conventional bone scanning , 1997, European Journal of Nuclear Medicine.
[81] J Dequeker,et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.
[82] G. Rubini,et al. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest. , 1992, Nuclear medicine communications.
[83] D. A. Ross,et al. Whole-body counting. , 1973, Seminars in nuclear medicine.
[84] I. Fogelman,et al. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate. , 1980, Annals of internal medicine.
[85] I. Fogelman,et al. 99mTc Diphosphonate Uptake Mechanism on Bone , 1987 .
[86] M. Piert,et al. Blood Flow Measurements with [15O]H2O and [18F]Fluoride Ion PET in Porcine Vertebrae , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[87] T. Ota,et al. Age-related change of technetium-99m-HMDP distribution in the skeleton. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[88] D. Pearson,et al. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[89] N. D. Charkes. Skeletal blood flow: implications for bone-scan interpretation. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[90] J. Nuyts,et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[91] P. Delmas,et al. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. , 1994, The Journal of clinical endocrinology and metabolism.
[92] G. Hortobagyi,et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. , 1996, The New England journal of medicine.
[93] N. D. Charkes,et al. Studies in skeletal tracer kinetics. V: Computer-simulated Tc-99m (Sn)MDP bone-scan changes in some systemic disorders: concise communication. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[94] W. Armstrong,et al. Distribution, migration and binding of whole blood fluoride evaluated with radiofluoride. , 1960, The American journal of physiology.
[95] D. Pashley,et al. Fluoride renal clearance: a pH-dependent event. , 1976, The American journal of physiology.
[96] J. Ekstrand,et al. Fluoride bioavailability after intravenous and oral administration: Importance of renal clearance and urine flow , 1978, Clinical pharmacology and therapeutics.
[97] V. Vigorita,et al. Localization of technetium‐99m methylene diphosphonate in bone using microautoradiography , 1986, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[98] A. Peters. Bone Turnover in Osteoporosis , 1993 .
[99] R. Eastell. Treatment of postmenopausal osteoporosis. , 1998, The New England journal of medicine.
[100] R. Wootton,et al. The clinical measurement of skeletal blood flow. , 1976, Clinical science and molecular medicine.
[101] E C Frey,et al. Quantitative single-photon emission computed tomography: basics and clinical considerations. , 1994, Seminars in nuclear medicine.
[102] I. Fogelman,et al. The role of positron emission tomography in skeletal disease. , 2001, Seminars in nuclear medicine.
[103] M. Hooper,et al. Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis , 2000, Osteoporosis International.
[104] G. Hodgson,et al. The relation of radionuclide uptake by bone to the rate of calcium mineralization. II: Patient studies using 99Tcm-MDP. , 1989, The British journal of radiology.
[105] R. Lindsay,et al. SKELETAL UPTAKE OF DIPHOSPHONATE Method for Prediction of Post-menopausal Osteoporosis , 1980, The Lancet.
[106] W. S. Snyder,et al. ICRP Publication 20: Alkaline Earth Metabolism in Adult Man , 1973 .
[107] T. Einhorn,et al. The Bone Organ System: Form and Function , 2001 .
[108] D. Taves. Electrophoretic Mobility of Serum Fluoride , 1968, Nature.
[109] P. Mcnair,et al. GFR-corrected 24-hour whole body retention of diphosphonate: an improved index of bone metabolism. , 1988, Scandinavian journal of clinical and laboratory investigation.
[110] P. Tothill,et al. Post-mortem migration of bone-seeking radionuclides in the rat and rabbit and its effect on estimates of bone uptake. , 1978, Clinical science and molecular medicine.
[111] S. Hughes,et al. Fluid space in bone. , 1978, Clinical orthopaedics and related research.
[112] J. Bevan,et al. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed). , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[113] C. Marcelli,et al. Evolution of Lumbar Bone Mineral Content During Adolescence and Adulthood: A Longitudinal Study in 395 Healthy Females 10–24 Years of Age and 206 Premenopausal Women , 1999, Osteoporosis International.